Charcoal

DRUG3 trials

Sponsors

Sanofi, Orion Corporation, Orion Pharma

Conditions

AsthmaHealthy SubjectsMultiple SclerosisType 2 Diabetes Mellitus

Phase 1

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

CompletedNCT03073057

Orion Corporation, Orion PharmaAsthma

Start: 2016-01-31End: 2016-03-31Updated: 2017-03-08

Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects

CompletedNCT03802487

SanofiHealthy Subjects, Type 2 Diabetes Mellitus

Start: 2019-01-14End: 2019-03-28Updated: 2022-04-25

Phase 3

Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis

CompletedNCT01863888

SanofiMultiple Sclerosis

Start: 2013-10-31End: 2015-01-31Updated: 2015-03-13

Related Papers

Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS

2017-01-012 citations

TERI-DYNAMIC: Exploring the Impact of Teriflunomide on Immune Cell Population Size, Receptor Repertoire, and Function in Patients With RRMS (P5.282)

Neurology2016-04-055 citations